Results 61 to 70 of about 6,561 (215)
Periocular Lentigo Maligna: To Treat or Not to Treat?
Vision Pan-America, 2014 Lentigo maligna (LM) affecting the periocular skin represents a challenge in its diagnosis and management. LM has a very slow rate of malignant transformation; however, with our aging population the progression towards malignant melanoma is concerning ...
Alison Gail Kartush +2 more
doaj +1 more source
JDDG: Journal der Deutschen Dermatologischen Gesellschaft, Volume 24, Issue 3, Page 302-315, March 2026.Summary Defensive medicine refers to diagnostic or therapeutic actions taken primarily to reduce legal liability rather than to benefit the patient. In dermatopathology, defensive practices manifest in frequent immunohistochemical testing, overly cautious report phrasing, and reliance on multidisciplinary tumor boards.
Cornelia Sigrid Lissi Müller +2 more
wiley +1 more source
SOX10 commonly stains scar in Mohs sections [PDF]
, 2020 Sox10 immunostaining is used for the diagnosis and margin evaluation of melanocytic lesions. Sox10 was initially thought not to stain fibrohistiocytic processes.
Donaldson, Matthew R, Weber, L Arthur
core
Dermatoscopic features of cutaneous non-facial and non-acral lentiginous growth pattern melanomas
Dermatology Practical & Conceptual, 2014 Background: The dermatoscopic features of facial lentigo maligna (LM), facial lentigo maligna melanoma (LMM) and acral lentiginous melanoma (ALM) have been well described. This is the first description of the dermatoscopic appearance of a clinical series
Jeff Keir
doaj +1 more source
Diagnosis and Management of Lentigo Maligna: Clinical Presentation and Comprehensive Review
Journal of Skin Cancer, 2021 Lentigo maligna (LM), also known as Hutchinson’s melanotic freckle, is a form of in situ melanoma characterized by the proliferation of atypical melanocytes along the basal epidermis in sun-damaged skin.
Piyu Parth Naik
doaj +1 more source
Scalp Melanoma in a Young Patient With Systemic Sarcoidosis: Multidisciplinary Approach
Clinical Case Reports, Volume 14, Issue 2, February 2026.ABSTRACT Often discovered at late stages, scalp melanoma presents unique diagnostic difficulties. Timely detection via public awareness, education, and comprehensive clinical assessment is essential for survival rate improvement. This case report shows the significance of multidisciplinary care and targeted therapies which can achieve remission even in
Nicolò Mori +17 more
wiley +1 more source
Use of the “spaghetti” technique for surgical treatment of lentigo maligna [PDF]
Revista Brasileira de Cirurgia Plástica, 2019 Lentigo maligna (LM) is a melanoma in situ that commonly presents as a macula with progressive and irregularly pigmented growth, especially in the face of elderly people with sun-damaged skin.
Gabriela Suemi Shimizu +7 more
doaj +1 more source
Clinical Case Reports, Volume 14, Issue 2, February 2026.ABSTRACT The aim of this case report is to introduce the reader to dermatofibrosarcoma protuberans (DFSP). In addition to the general characteristics of this rare skin tumor with possible metastatic potential, we also describe an atypical genetic finding that made our patient's case unique.
Jakub Bejbl +3 more
wiley +1 more source
Case report. A rare case of giant basal cell carcinoma and malignant melanoma [PDF]
, 2018 The presence of two several skin lesions in the same patient is a rare occurrence in dermatological findings. The associations of malignant melanoma (MM) and giant basal cell carcinoma (BCC) within the same patient have only been described in few cases
Izzo, L. +3 more
core +1 more source
Melanoma: Pathogenesis and Targeted Therapy
MedComm, Volume 7, Issue 1, January 2026.The treatment landscape for advanced melanoma has evolved significantly. BRAF–MEK inhibitor combinations are standard for BRAF‐mutant melanoma, whereas targeting NRAS mutations is more challenging, with MEK inhibitors like tunlametinib emerging as an option.
Yang Fu +5 more
wiley +1 more source